Inogen Q1 revenue up 3.4% to $85.1M; net loss widens to $8.3M

Inogen Inc

2026-Q1 EPS reported -$0.30 revenue$85,109,000

GAAP net loss of $8.3M vs $6.2M loss in Q1 2025; adjusted net loss $4.0M vs $2.9M.
Adjusted EBITDA turned negative at -$1.4M vs +$0.04M a year ago on R&D investments.
Cash and securities $111.5M, no debt; $30M share repurchase authorized, $1.9M executed.
Introduced Aurora CPAP masks in U.S. and launched Rove 6 POC in Brazil.
Appointed Jason Richardson as CFO and Dominic Hulton as CMO; reiterated full-year 2026 revenue guidance.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Inogen Inc reported first quarter ended March 31, 2026 results: revenue $85.1 million, net income GAAP net loss for the first quarter of 2026 was $8.3 million. Guidance reaffirmed.

Period: first quarter ended March 31, 2026
Revenue: $85.1 million
Net income: GAAP net loss for the first quarter of 2026 was $8.3 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

total revenue in the first quarter of 2026 was $85.1 million

View on SEC.gov

Browse all earnings releases →

Inogen Inc filing history →

Source: SEC EDGAR

accession 0001294133-26-000014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.